AtaiBeckley (ATAI) FCF Margin (2021 - 2026)
AtaiBeckley (ATAI) recorded quarterly FCF Margin of 2210.69% in Q1 2026, down 89.83% quarter-over-quarter from 1164.57% in Q1 2025, and down 104613.0% on a YoY basis from N/an in Q1 2025.
AtaiBeckley (ATAI) FCF Margin (2021 - 2026) Analysis & Trends
AtaiBeckley has disclosed FCF Margin across 5 years of filings, most recently posting 3052.87% for Q3 2025.
- FCF Margin for Q3 2025 came in at 3052.87%, up 4529963.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 2619.34% (up 2160543.0% YoY), and the FY2024 annual result was 26767.21%, up 12738.0% from the prior year.
- FCF Margin was 2210.69% for Q1 2026 at AtaiBeckley, down from 1164.57% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1164.57% in Q1 2025 to a low of 2210.69% in Q1 2026.
- The 5-year median for FCF Margin is 13065.17% (2022), against an average of 44334.26%.
- Across the five-year window, FCF Margin plunged 10644583 bps in 2022 and soared 9604009 bps in 2023, its largest moves.
- AtaiBeckley's FCF Margin stood at 9049.57% in 2021, then plunged by 805 bps to 81863.16% in 2022, then tumbled by 50 bps to 122455.56% in 2023, then sank by 65 bps to 202508.33% in 2024, then surged by 98 bps to 3052.87% in 2025.
- The last three FCF Margin figures came in at 3052.87% (Q3 2025), 1977.89% (Q2 2025), and 1164.57% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -2,210.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,210.69% |
| Sep 30, 2025 | -3,052.87% |
| Jun 30, 2025 | -1,977.89% |
| Mar 31, 2025 | -1,164.57% |
| Mar 31, 2025 | -1,164.57% |
| Dec 31, 2024 | -202,508.33% |
| Sep 30, 2024 | -48,352.50% |
| Jun 30, 2024 | -5,944.32% |
| Dec 31, 2023 | -122,455.56% |
| Sep 30, 2023 | -21,105.75% |
| Jun 30, 2023 | -13,170.93% |
| Mar 31, 2023 | -57,813.51% |
| Dec 31, 2022 | -81,863.16% |
| Sep 30, 2022 | -117,145.83% |
| Jun 30, 2022 | -12,959.41% |
| Dec 31, 2021 | -9,049.57% |
| Sep 30, 2021 | -10,700.00% |
| Mar 31, 2021 | -84.00% |